Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

被引:32
|
作者
Schilder, C. M. T. [1 ]
Seynaeve, C. [2 ]
Linn, S. C. [3 ]
Boogerd, W. [4 ,5 ]
Beex, L. V. A. M. [6 ]
Gundy, C. M. [1 ]
Nortier, J. W. R. [7 ]
van de Velde, C. J. H. [8 ]
van Dam, F. S. A. M. [1 ]
Schagen, S. B. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, Erasmus Med Ctr, NL-3008 AE Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands
[5] Slotervaart Med Ctr, Dept Neurol, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[7] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands
关键词
Breast cancer; Postmenopausal; Cognitive function; Neuropsychological testing; Psychological function; Adjuvant systemic treatment; REPRODUCTIVE PERIOD; CHEMOTHERAPY; RISK; IMPAIRMENT; WOMEN; DYSFUNCTION; DEMENTIA; PEOPLE;
D O I
10.1016/j.critrevonc.2009.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to identify medical and psychological predictors for cognitive performance of breast cancer (BC) patients before the start of adjuvant systemic treatment and to compare cognitive performance between BC patients and healthy controls adjusting for medical and psychological variables. Material: 205 postmenopausal BC patients underwent pre-treatment neuropsychological tests and provided medical and psychological data. 124 healthy controls underwent the same assessment. Results: 'Treatment for diabetes mellitus' and/or 'hypertension', 'less hours spent on cognitively stimulating activities', 'fewer days since surgery' and 'more reproductive years' were associated with worse cognitive performance in the BC patients, independent of age and IQ. Cognitive differences between BC patients and healthy controls could partly be explained by the evaluated variables. Conclusion: The results stress the need for adjustment for pre-treatment cognitive differences between study groups, and also indicate that further research into pre-treatment cognitive dysfunction is warranted. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [31] Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
    Gueth, U.
    Huang, D. J.
    Schoetzau, A.
    Zanetti-Daellenbach, R.
    Holzgreve, W.
    Bitzer, J.
    Wight, E.
    BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 428 - 433
  • [32] Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
    U Güth
    D J Huang
    A Schötzau
    R Zanetti-Dällenbach
    W Holzgreve
    J Bitzer
    E Wight
    British Journal of Cancer, 2008, 99 : 428 - 433
  • [33] A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer
    G. Nagel
    B. Röhrig
    H. Hoyer
    U. Wedding
    D. Katenkamp
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 183 - 191
  • [34] A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer
    Nagel, G
    Röhrig, B
    Hoyer, H
    Wedding, U
    Katenkamp, D
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (03) : 183 - 191
  • [35] Need for weight management among postmenopausal early breast cancer patients receiving adjuvant endocrine therapy
    Harvie, Michelle
    Howell, Tony
    WOMENS HEALTH, 2005, 1 (02) : 205 - 222
  • [36] Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study
    Hagen, Kari Britt
    Aas, Turid
    Kvaloy, Jan Terje
    Soiland, Hdvard
    Lind, Ragna
    BREAST, 2019, 44 : 52 - 58
  • [37] Comparison of Coping, Psychological Distress, and Level of Functioning in Patients With Gastric and Colorectal Cancer Before Adjuvant Chemotherapy
    Calderon, Caterina
    Jimenez-Fonseca, Paula
    Jara, Carlos
    Hernandez, Raquel
    Martinez de Castro, Eva
    Varma, Sonal
    Ghanem, Ismael
    Carmona-Bayonas, Alberto
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 56 (03) : 399 - 405
  • [38] Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer
    Li, Jingmei
    Humphreys, Keith
    Eriksson, Louise
    Edgren, Gustaf
    Czene, Kamila
    Hall, Per
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18) : 2249 - U50
  • [39] Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer
    Nabholtz J.-M.
    Mouret-Reynier M.-A.
    Durando X.
    van Praag I.
    Nayl B.
    Ferriere J.-P.
    Chollet P.
    Indian Journal of Surgical Oncology, 2010, 1 (1) : 19 - 26
  • [40] Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast Cancer
    Post, Kathryn E.
    Ahmad, Zeba
    Jankauskaite, Greta
    Centracchio, Joely
    Oswald, Laura
    Horick, Nora
    Park, Elyse R.
    Temel, Jennifer S.
    Greer, Joseph A.
    Jacobs, Jamie
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (01) : 88 - 97